Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Aubry

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
Annales Pharmaceutiques Francaises|April 19, 2023
Impact of clinical pharmacist interventions in a bone and joint infection orthoseptic surgery unitJulie Coiffard, Alexandra Aubry, Alexandre Bleibtreu, et al.
Journal of Clinical Microbiology|March 26, 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolatesFlorence Brossier, Nicolas Veziris, Alexandra Aubry, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivoNicolas Veziris, Chantal Truffot-Pernot, Alexandra Aubry, et al.
Journal of Toxicology and Environmental Health. Part A|October 13, 2018
Assessment of functional nanomaterials in medical applications: can time mend public and occupational health risks related to the products' fate?Christophe Bressot, Alexandra Aubry, Cécile Pagnoux, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activityAlexandra Aubry, Xiao-Su Pan, L Mark Fisher, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in miceBaohong Ji, Aurélie Chauffour, Alexandra Aubry, et al.
Microbiology Spectrum|November 15, 2022
Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth TimesPauline Vidal, Eric Fourniols, Helga Junot, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 3, 2012
Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTDAmélie Darmon, Jérémie Piton, Mélanie Roué, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
Annales Pharmaceutiques Francaises|April 19, 2023
Impact of clinical pharmacist interventions in a bone and joint infection orthoseptic surgery unitJulie Coiffard, Alexandra Aubry, Alexandre Bleibtreu, et al.
Journal of Clinical Microbiology|March 26, 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolatesFlorence Brossier, Nicolas Veziris, Alexandra Aubry, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivoNicolas Veziris, Chantal Truffot-Pernot, Alexandra Aubry, et al.
Journal of Toxicology and Environmental Health. Part A|October 13, 2018
Assessment of functional nanomaterials in medical applications: can time mend public and occupational health risks related to the products' fate?Christophe Bressot, Alexandra Aubry, Cécile Pagnoux, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activityAlexandra Aubry, Xiao-Su Pan, L Mark Fisher, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in miceBaohong Ji, Aurélie Chauffour, Alexandra Aubry, et al.
Microbiology Spectrum|November 15, 2022
Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth TimesPauline Vidal, Eric Fourniols, Helga Junot, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 3, 2012
Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTDAmélie Darmon, Jérémie Piton, Mélanie Roué, et al.
Pageof 10